Sensei Biotherapeutics, Inc. (SNSE) Financials

SNSE Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 74.4 million 9.5 million
2023-09-30 81.7 million 10.7 million
2023-06-30 89.6 million 10.4 million
2023-03-31 107.9 million 13.1 million

SNSE Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -6.2 million 1.1 million
2023-09-30 -4.7 million 1.0 million
2023-06-30 -9.5 million 1.1 million
2023-03-31 -11.9 million 1.2 million

SNSE Net Income

No data available :(

SNSE Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 65.8 million - 6.2 million
2023-09-30 72.0 million - 6.8 million
2023-06-30 78.8 million - 7.3 million
2023-03-31 8.1 million - 7.8 million

SNSE Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 25.0 million
2023-09-30 25.5 million
2023-06-30 30.5 million
2023-03-31 30.9 million

SNSE Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 4.5 million 3.6 million 135000
2023-09-30 - 3.8 million 3.9 million -
2023-06-30 29000 4.8 million 5.4 million -
2023-03-31 151000 5.2 million 5.8 million -

SNSE Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 2.8 million 135000
2023-09-30 - 455000
2023-06-30 - 491000
2023-03-31 - 477000

SNSE

Price: $1.75

52 week price:
0.51
1.93

Earnings Per Share: -1.22 USD

P/E Ratio: -0.61

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 18884

Market Capitalization: 27.9 million

Links: